Related Experiment Video
Updated: Apr 21, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer
Ken-Ichi Takayama1, Takashi Suzuki, Shuichi Tsutsumi
1Departments of Anti-Aging Medicine (K.T., T.U., S.I.) and Geriatric Medicine (K.T., T.U., S.I.) and Department of Urology (T.F., Y.H.), Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; Department of Pathology (T.S.), Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan; Genome Science Division (Sh.T., H.A.), Research Center for Advanced Science and Technology, The University of Tokyo, Meguro-ku, Tokyo 153-8904, Japan; Department of Urology (Sa.T.), Nihon University School of Medicine, Itabashi-ku, Tokyo 173-0032, Japan; and Division of Gene Regulation and Signal Transduction (S.I.), Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama, 350-1241, Japan.
Abstract:
The transcriptional network of the androgen receptor (AR), a key molecule of prostate cancer, is frequently modulated by interactions with other transcriptional factors such as forkhead box protein A1 (FOXA1). However, global regulatory mechanisms of AR signaling mediated by such factors have not been well investigated. Here we conducted a chromatin immunoprecipitation sequence analysis, which revealed that another FOX family, FOXP1, is specifically regulated by both AR and FOXA1. We also found that FOXP1 acts as a tumor suppressor in prostate cancer through inhibiting cell proliferation and migration. We generated an extensive global map of FOXP1 binding sites and found that FOXP1 is directly involved in AR-mediated transcription. We demonstrated that FOXP1 has a repressive effect on AR-induced transcriptional activity or histone modification in enhancer regions. Moreover, by a global analysis of androgen-mediated transcriptional networks, we observed enrichment of FOXP1 binding genes in the gene cluster negatively regulated by FOXP1. Evaluation of FOXP1 expression in clinical samples indicated that the decreased expression of FOXP1 is another prognostic factor of prostate cancer. Taken together, our results suggest a novel mechanism in which AR-induced FOXP1 functions as a direct modulator of the AR and FOXA1 centric global transcriptional network.
Insights
Forkhead box protein P1 (FOXP1) is regulated by androgen receptor (AR) and forkhead box protein A1 (FOXA1) in prostate cancer. Decreased FOXP1 expression indicates a poor prognosis and suggests FOXP1 acts as a tumor suppressor.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Androgen receptor (AR) signaling is crucial in prostate cancer.
- Interactions with transcription factors like forkhead box protein A1 (FOXA1) modulate AR networks.
- Global regulatory mechanisms of AR signaling require further investigation.
Purpose of the Study:
- Investigate the role of FOXP1 in AR-mediated transcriptional regulation in prostate cancer.
- Determine if FOXP1 acts as a tumor suppressor.
- Map FOXP1 binding sites and analyze its impact on AR signaling.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) to identify FOXP1 binding sites.
- Analysis of gene expression and histone modification in enhancer regions.
- Evaluation of FOXP1 expression in clinical prostate cancer samples.
Main Results:
- FOXP1 is directly regulated by AR and FOXA1.
- FOXP1 inhibits prostate cancer cell proliferation and migration, acting as a tumor suppressor.
- FOXP1 directly modulates AR-mediated transcription, repressing activity in enhancer regions.
- Decreased FOXP1 expression correlates with a poor prognosis in prostate cancer patients.
Conclusions:
- FOXP1 is a novel direct modulator of the AR and FOXA1 transcriptional network in prostate cancer.
- FOXP1 functions as a tumor suppressor by inhibiting AR signaling.
- Reduced FOXP1 expression is a prognostic biomarker for prostate cancer.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

